Filtered By:
Specialty: Research
Condition: Arthritis
This page shows you your search results in order of date.
Order by Relevance | Date
Total 25 results found since Jan 2013.
Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis
CONCLUSION: Patients with SAD present an increased risk of CV morbidity and mortality, which should be considered when establishing therapeutic strategies. These findings support the role of systemic inflammation in the development of atherosclerosis-driven disease.PMID:37650912 | DOI:10.1007/s00392-023-02291-4
Source: Clin Med Res - August 31, 2023 Category: Research Authors: Claudia Asenjo-Lobos Leticia Gonz ález Juan Francisco Bulnes Marta Roque Paula Mu ñoz Venturelli Gonzalo Mart ínez Rodríguez Source Type: research
Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis
ConclusionsHypouricemia may be a potential risk factor of CVDs in RA patients
Source: European Journal of Medical Research - November 21, 2022 Category: Research Source Type: research
Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
AbstractAngiogenesis is a vital biological process involving blood vessels forming from pre-existing vascular systems. This process contributes to various physiological activities, including embryonic development, hair growth, ovulation, menstruation, and the repair and regeneration of damaged tissue. On the other hand, it is essential in treating a wide range of pathological diseases, such as cardiovascular and ischemic diseases, rheumatoid arthritis, malignancies, ophthalmic and retinal diseases, and other chronic conditions. These diseases and disorders are frequently treated by regulating angiogenesis by utilizing a va...
Source: European Journal of Medical Research - November 4, 2022 Category: Research Source Type: research
Real-world impact of disease on functioning and activity: what is missed when using general instruments to estimate quality-adjusted life year
CONCLUSION: Differences in rankings of disease severity by metric indicate that the results of cost-utility analyses might be biased against treatments for certain diseases. As patient preferences for clinical outcomes vary, the full burden of disease should be considered in evaluations. Restricting access to treatments based on an incomplete estimate of burden could lead to misallocation of resources and a withholding of therapies that patients find valuable.PMID:34775901 | DOI:10.1080/03007995.2021.2006535
Source: Current Medical Research and Opinion - November 15, 2021 Category: Research Authors: Tingjian Yan Jesse D Ortendahl Eunice Chang Zac Wessler Amanda L Harmon Michael S Broder Source Type: research
Associations between High-Sensitivity C-Reactive Protein and Non-Communicable Diseases in an Asian Population: Findings from the IFLS Study
Biomarkers. 2021 May 29:1-34. doi: 10.1080/1354750X.2021.1936177. Online ahead of print.ABSTRACTThere has been no comprehensive study on how high-sensitivity C-reactive protein (hs-CRP) level, a biomarker of inflammation, is associated with subsequent diagnoses of various non-communicable diseases (NCDs) in Asians. Our study is the first to do so to better compare these associations in an Asian population. This is a nationwide longitudinal study of 3,410 male and 4,004 female participants of the RAND Indonesian Family Life Survey with a mean age of 42.4 years, to examine associations between increasing hs-CRP levels and ri...
Source: Biomarkers - May 31, 2021 Category: Research Authors: Nirmin Juber Chien-Chang Lee Jason J Liu Source Type: research
